Agentic AI platform for clinical development closes a $37.3M Series B led by Merck's health fund and S32.
Kyowa Kirin adopts Benchling's AI R&D platform with Cognizant handling the rollout at two research parks.
Novo Nordisk partners with provider data company H1 to bring AI to trial design, enrollment and site selection.
AstraZeneca CEO Pascal Soriot said the company is using AI to de-risk late-stage clinical trials and accelerate regulatory submissions.
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug discovery.